The authors used a single institution data base to assess very long-term outcomes after AVR to determine the effects of prosthesis-patient mismatch. Among 673 pts, 24% had mismatch. Mean follow-up was nearly 18 years. On multivariable analysis, mismatch was not a significant determinant of long-term survival.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
April 12, 2016
April 8, 2016
ECMO is widely used for cardiogenic shock treatment. Since peripheral V-A ECMO will increase LV afterload and IABP therapy can counterbalance it, will IABP combined with ECMO improve the outcomes?
April 5, 2016
In this manuscript the authors report on their findings in a systematic review and meta-analysis of 18 studies looking into the effect on outcomes of balloon predilatation in patients undergoing transcatheter aortic valve implantation (TAVI).
April 4, 2016
This video demonstrates the use of a half-pantaloon patch (Florida shaped) to create a pulmonary artery reconstruction after coronary transfer for ALCAPA.
April 3, 2016
Neil Moat, one of the busiest British surgeons involved directly and consistently in TAVR, discusses PARTNER 2 and SURTAVI, paying particular attention to the health economics of low-risk TAVR and the implication of reduced profile devices.
April 3, 2016
The PARTNER 2A trial randomized 2032 patients at intermediate operative risk (mean STS score of 6) to undergo either transcatheter or surgical aortic valve replacement. The primary endpoint of all-cause death or disabling stroke at 2 years was comparable for the two treatments: TAVR 19.3% versus SAVR 21.1%.
April 3, 2016
In a propensity-matched analysis, Rosenblum and colleagues found that hybrid revascularization as compared with coronary artery bypass grafting with either single or bilateral internal mammary artery grafts was superior in terms of secondary short-term outcomes (e.g.
March 31, 2016
The fourth (re- )classification of cardiopericardial tumours came from the World Health Organisation last year, 11 years after the third. In particular, the malignant fibrous histiocytomas are re classified as undifferentiated pleomorphic sarcomas.
March 31, 2016
A commentary and follow-up comment on last year's ERICCA and RIPHeart- related publications in the NEJM.
March 31, 2016
A panel of leading cardiac surgeons met at the 2016 SCTS Annual Meeting in Birmingham, United Kingdom, to discuss the current state of cardiac surgery, and what is on the horizon for the subspecialty.